Trinity Innovation Bioventure Singapore is a licensed biomed venture capital fund focusing on innovation and value investment with deep insight and experience on Asia markets.

We are part of the Trinity Innovation Fund group, founded in 2018, managing multiple VC funds in the region.

We are an experienced team led by industrial veterans who have managed multiple VC funds and invested over dozens of biotech companies.

Our Strength

Access to China market through synergy with TIF: Two organizations, One Team
Multi-dimensional value-added post investment to enhance possibility of success and returns
Clear investment thesis: In Asia, for Global; Leverage regional synergy and realize future value
Best-in-class team in biomed investment with strong track record

Our Focus

TIBS seeks to invest and build great companies that emerging biotechnology leads to innovative therapeutics to address global unmet medical needs.

We focus on incubating and growing potential early-stage biotech start-ups with breakthrough platform technology, differentiated scientific merit and commercial value.

Our Core Competency

Value Discovery: Select investment projects based on precise judgements from in-depth research
Project Incubation: Incubate cutting-edge science or outstanding entrepreneurs with innovative approaches. Unique incubation strategy:
project management by investment team to increase the asset value;
management team recruitment to maximize the equity value and capital efficiency
Help entrepreneurs to grow rapidly with proprietary foresight, industry understanding and resources

Venture Capital Careers

Trinity Innovation Bioventure Singapore